Medicare Enrolled

Dr. Ricky Hsu, MD

Internal Medicine · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
352 7TH AVE, New York, NY 10001
2126277560
In practice since 2006 (20 years)
NPI: 1568491967 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hsu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hsu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hsu

Dr. Ricky Hsu is an internal medicine specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hsu performed 1,170 Medicare services across 487 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hsu received a total of $966,955 from 50 pharmaceutical and/or device companies across 1557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hsu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 27% volume in NY $966,955 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,170
Medicare services
Top 27% in NY for internal medicine
487
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~58 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
380 $107 $388
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
343 $8 $10
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
147 $67 $266
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
105 $11 $62
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
41 $12 $34
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
30 $29 $30
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
27 $149 $420
COVID-19 vaccine administration
Administration of a single dose of the coronavirus vaccine.
21 $37 $40
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
20 $70 $72
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
17 $65 $96
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
15 $39 $50
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $32 $155
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
12 $29 $30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$966,955
Total received (2018-2024)
Avg $138,136/year across 7 years
Top 0% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
1,557
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$924,245 (95.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$23,118 (2.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,592 (2.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$140,459
2023
$160,151
2022
$167,637
2021
$99,021
2020
$103,762
2019
$223,021
2018
$72,903

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ViiV Healthcare Company
$88,243
EMD Serono, Inc.
$21,080
Gilead Sciences, Inc.
$17,242
Merck Sharp & Dohme LLC
$13,151
Bausch Health US, LLC
$162
ABBVIE INC.
$143
Theratechnologies Inc.
$77
Antares Pharma, Inc.
$60
Napo Pharmaceuticals Inc
$59
Lilly USA, LLC
$53
ROCHE MOLECULAR SYSTEMS, INC.
$53
Otsuka America Pharmaceutical, Inc.
$50
Hologic Sales and Service, LLC
$36
AstraZeneca Pharmaceuticals LP
$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
Top 3 companies account for 90.1% of 2024 payments
All-time payments by company (2018-2024) ›
ViiV Healthcare Company
$576,333
Janssen Products, LP
$142,602
Gilead Sciences, Inc.
$80,988
Merck Sharp & Dohme Corporation
$53,340
EMD Serono, Inc.
$53,036
Merck Sharp & Dohme LLC
$26,357
Janssen Scientific Affairs, LLC
$13,086
Theratechnologies Inc.
$10,057
ROCHE DIAGNOSTICS INTERNATIONAL LTD
$4,144
Janssen Biotech, Inc.
$1,989
GlaxoSmithKline, LLC.
$1,148
Allergan Inc.
$347
AbbVie, Inc.
$298
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$286
AstraZeneca Pharmaceuticals LP
$264
Bausch Health US, LLC
$246
AbbVie Inc.
$202
Mylan Pharmaceuticals Inc.
$192
Takeda Pharmaceuticals U.S.A., Inc.
$190
Shire North American Group Inc
$186
Allergan, Inc.
$159
ABBVIE INC.
$143
Antares Pharma, Inc.
$126
ROCHE MOLECULAR SYSTEMS, INC.
$108
CSL Behring
$93
Endo Pharmaceuticals Inc.
$83
Grifols USA, LLC
$81
Mylan Institutional Inc.
$77
Amarin Pharma Inc.
$63
Nestle HealthCare Nutrition Inc.
$62
Napo Pharmaceuticals Inc
$59
Hologic Sales and Service, LLC
$53
Lilly USA, LLC
$53
Kowa Pharmaceuticals America, Inc.
$50
Otsuka America Pharmaceutical, Inc.
$50
Octapharma USA, Inc.
$47
Supernus Pharmaceuticals, Inc.
$41
SANOFI-AVENTIS U.S. LLC
$41
Bio Products Laboratory USA, Inc.
$35
Janssen Pharmaceuticals, Inc
$35
Romark Laboratories, LC
$31
Neurocrine Biosciences, Inc.
$24
Astellas Pharma US Inc
$23
INSYS Therapeutics Inc
$22
Horizon Pharma plc
$20
Novo Nordisk Inc
$20
Aytu Bioscience, Inc
$19
Aytu BioScience, Inc
$16
Oxford Immunotec USA Inc
$16
Purdue Pharma L.P.
$14
Top 3 companies account for 82.7% of all-time payments
Associated products mentioned in payments ›
APLENZIN · APRETUDE · APTIMA · AVEED · Alinia Tablets 500mg 30 count bottle · Androgel · BREZTRI · BYSTOLIC · Biktarvy · CABENUVA · CUTAQUIG · CUVITRU · Cimduo · Creon · DELSTRIGO · DIFICID · DOVATO · Descovy · EDURANT · EGRIFTA · FARXIGA · GAMMAGARD · Gammaplex · Gamunex-C · HYQVIA · Hizentra · Humira · INGREZZA · ISENTRESS · JULUCA · LINZESS · Livalo · MAVYRET · MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT · MOUNJARO · MYRBETRIQ · Mavyret · Mytesi · NASCOBAL · NOXAFIL · Natesto · Otrexup · Ozempic · PANZYGA · PENNSAID · PIFELTRO · PRALUENT · PREVYMIS · PREZCOBIX · PREZISTA · REXULTI · RUKOBIA · SEROSTIM · SYMBICORT · SYMPROIC · SYMTUZA · SYNDROS · Serostim · Symfi · Symfi Lo · Symtuza · TIVICAY · TLANDO · TRELEGY ELLIPTA · TRIUMEQ · TROGARZO · TSPOT TB TEST · Trintellix · VIBERZI · VRAYLAR · VYVANSE · Vascepa · Veklury · Vemlidy · WELLBUTRIN · XARELTO · XIAFLEX · XIFAXAN · XIFAXANIBSD · XYOSTED · Xembify · ZENPEP · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in NY.

Looking for an internal medicine specialist in New York?
Compare internal medicine physicians in the New York area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
11,036
Per 100K population
678.0
County median income
$104,553
Nearest hospital
BELLEVUE HOSPITAL CENTER
1.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hsu is a clinical cardiology specialist, with above-average Medicare volume (top 27% in NY), with speaking/promotional industry engagement in the top 0% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hsu experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hsu performed 380 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hsu receive payments from pharmaceutical companies?
Yes. Dr. Hsu received a total of $966,955 from 50 companies across 1,557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hsu's costs compare to other internal medicine physicians in New York?
Dr. Hsu's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hsu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →